Today's Market

Why are stocks up (or down) and what does the latest Nvidia news mean? Today’s Market will answer those questions and keep you informed about big stock market movers. We’ll also tell you about the latest Fed moves, what stocks Warren Buffett is buying, and which stocks look primed for a short squeeze. Today’s Market is the perfect pairing of InvestorPlace’s expert financial advice and critical stock and crypto news.

Top Stories

Market News

Mixed Market News Explained

By Richard Band
Negative data on housing starts doesn't derail homebuilders, positive earnings push tech stocks higher, and gold miners look more tempting.

Why You Shouldn’t Worry About Tepid Volume

By James Brumley, InvestorPlace Feature Writer
Trading volume for the first 10 days of the year is at its lowest point since 2007. Here's why most investors shouldn't break a sweat over it.

China Isn’t Blowing Up — at Least Not in 2012

By Charles Sizemore, Chief Investment Strategist, The Freeport Society
China isn't exactly crumbling at 8.9% growth. However, a few troubling economic indicators should shape how you invest there.

Bullion Authority Predicts $10,000 Gold

By Kyle Woodley, Senior Investing Editor, Kiplinger
Forget $2,000 gold, one expert thinks that's just the beginning. See why -- and when -- this bullion authority thinks we could actually hit that figure.

Market Reaching Short-term Overbought Levels

By Sam Collins, InvestorPlace Chief Technical Analyst
Buy on pullbacks rather than chasing stocks.

Why Aggressive Investors Need to Revisit Basic Materials

By Bryan Perry
Early indicators from earnings season are positive for the basic materials sector. Key upside technical reversals on rising volume are being seen in many stocks

3 Real Risks for the Price of Gold

By BullionVault
Aside from the expected year-end downturn in gold prices, here are some nearer-term risks that gold investors need to keep in mind.

Can Bulls Break the Next Bearish Barrier?

By Sam Collins, InvestorPlace Chief Technical Analyst
One of the most significant resistance lines sits just 12 points above the S&P 500’s close.

We’ve Found Cracks in the Market’s Armor

By Richard Band
Cracks are starting to appear in the market's armor. But amid skids in financials and miners, there's some decent buys to be found.

Stat of the Week: Consumer Credit Up 9.9%

By Louis Navellier, Editor, Growth Investor
It's the largest consumer credit surge since the post-9/11 recovery month of November 2001, which should increase fourth-quarter GDP growth.

Why Are So Many 2011 Losers Rallying Now?

By Daniel Putnam, InvestorPlace Contributor
Caveat emptor: This trend is mostly a New Year's reallocation by institutional and hedge fund managers -- which could turn on a dime. Be ready to bail fast.

Gold’s Rout STILL Isn’t Quite Done

By James Brumley, InvestorPlace Feature Writer
Gold prices have rallied since late December, but the comeback has been staged on a couple weak legs. Here's why another fall will precede a true rally.

Look to Natural Gas as the Future Fuel of America

By Richard Young, Editor, Intelligence Report
The increasing substitution of natural gas for oil is just starting to emerge and will offer great opportunities for long-term investors.

Ensure Your Financial and Personal Security ‘The Swiss Way’

By Richard Young, Editor, Intelligence Report
When investing in both financial and personal security, there's nothing better than being armed to the teeth with precious metals.

Monthly Market News Analysis for Investors

By Richard Young, Editor, Intelligence Report
My thoughts on some of the most newsworthy market news stories over the past month: AT&T/T-Mobile, banks, energy, recession and Vanguard.

European Bonds Recover … Before Friday’s Debt Downgrades

By Louis Navellier, Editor, Growth Investor
Europe was starting to look healthier last week after Italy and Spain conducted successful debt auctions, but it was short-lived as more downgrades cropped up.

Charts Say ‘Be Long or Be Wrong’

By Sam Collins, InvestorPlace Chief Technical Analyst
The market continues to ignore bad news and give off positive technical signals.

Are Pharma’s ‘Good Old Days’ Gone Forever?

By Barry Cohen, Health Care Writer
You bet they are: Patent losses, a higher bar for FDA approvals, and slew of smaller, nimbler rivals have reshaped the industry.

The Only 3 Ways the Euro Crisis Can End

By Jeff Reeves
They would all cause widespread pain, and investors need to consider the ramifications of each of them before adjusting their portfolios.
Load More Articles